Clinical Trial Data Sharing: Central Public-Private Portal May Expand Access

This article was originally published in The Pink Sheet Daily

13 Nov 2015
News

Brenda Sandburg @brendasandburg Brenda.Sandburg@informa.com

Executive Summary

J&J has gotten 25 requests for data through YODA project; BMJ study ranks GSK, J&J, Pfizer highest in making data publicly available and Gilead lowest.

Already Registered? Sign in to continue reading.

New to Pink Sheet? Start a free trial today!

Table
View full table

Topics

Industries
BioPharmaceutical
Subjects
Clinical Trials

Related Companies

ASK THE ANALYST
Email

Print
Bookmark
Share

Tags:

BioPharmaceutical Clinical Trials

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

PS077989

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

PS077989

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.

Clinical Trial Data Sharing: Central Public-Private Portal May Expand Access

News

Executive Summary

Related Content

J&J’s Clinical Data Disclosure Strategy Focuses On Collaboration With Yale University Group

Topics

Related Companies

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Register

Ask The Analyst

Email Article

Sign In To Set a Search Alert